Advanced Search

Show simple item record

dc.contributor.authorIsler B.
dc.contributor.authorFalconer C.
dc.contributor.authorVatansever C.
dc.contributor.authorÖzer B.
dc.contributor.authorÇınar G.
dc.contributor.authorAslan A.T.
dc.contributor.authorForde B.
dc.date.accessioned2024-02-04T13:30:11Z
dc.date.available2024-02-04T13:30:11Z
dc.date.issued2022
dc.identifier.issn00222615
dc.identifier.urihttps://doi.org/10.1099/jmm.0.001629
dc.identifier.urihttp://hdl.handle.net/11446/4861
dc.description.abstractIntroduction. Aminoglycosides are used for the treatment of carbapenemase-producing Klebsiella pneumoniae (CPK) infections. 16S rRNA methyltransferases (RMTs) confer resistance to all aminoglycosides and are often cocarried with NDM. Hypothesis/Gap Statement. There is a dart of studies looking at the aminoglycoside resistance mechanisms for invasive CPK isolates, particularly in OXA-48 endemic settings. Aim. We aimed to determine the prevalence of RMTs and their association with beta lactamases and MLSTs amongst aminoglycoside-resistant CPK bloodstream isolates in an OXA-48 endemic setting. Methodology. CPK isolates (n=181), collected as part of a multicentre cohort study, were tested for amikacin, gentamicin and tobramycin susceptibility using custom-made sensititre plates (GN2XF, Thermo Fisher Scientific). All isolates were previously subjected to whole-genome sequencing. Carbapenemases, RMTs, MLSTs and plasmid incompatibility groups were detected on the assembled genomes. Results. Of the 181 isolates, 109(60%) were resistant to all three aminoglycosides, and 96 of 109(88%) aminoglycoside-resistant isolates carried an RMT (85 ArmA, 10 RmtC, 4 RmtF1; three isolates cocarried ArmA and RmtC). Main clonal types associated with ArmA were ST2096 (49/85, 58%) and ST14 (24/85, 28%), harbouring mainly OXA-232 and OXA-48 +NDM, respectively. RmtC was cocarried with NDM (5/10) on ST395, and NDM +OXA-48 or NDM +KPC (4/10) on ST14, ST15 and ST16. All RMT producers also carried CTX-M-15, and the majority cocarried SHV-106, TEM-150 and multiple other antibiotic resistance genes. The majority of the isolates harboured a combination of IncFIB, IncH and IncL/M type plasmids. Non-NDM producing isolates remained susceptible to ceftazidime-avibactam. Conclusion. Aminoglycoside resistance amongst CPK bloodstream isolates is extremely common and mainly driven by clonal spread of ArmA carried on ST2096 and ST14, associated with OXA-232 and OXA48 +NDM carriage, respectively. © The Authors.en_US
dc.description.sponsorshipPfizer: 56644459; Queensland Governmenten_US
dc.description.sponsorshipThis work was supported by Pfizer Global Medical Grants (grant number 56644459). Dr Brian Forde’s research is supported by Advance Queensland Industry Research Fellowship from the Queensland Government.en_US
dc.language.isoengen_US
dc.publisherMicrobiology Societyen_US
dc.relation.ispartofJournal of Medical Microbiologyen_US
dc.identifier.doi10.1099/jmm.0.001629
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject16S rRNA methyltransferaseen_US
dc.subjectaminoglycoside resistanceen_US
dc.subjectArmAen_US
dc.subjectbloodstreamen_US
dc.subjectcarbapenem-resistanten_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectNDMen_US
dc.subjectOXA-232en_US
dc.subjectOXA-48en_US
dc.subjectamikacinen_US
dc.subjectaminoglycosideen_US
dc.subjectavibactam plus ceftazidimeen_US
dc.subjectbeta lactamaseen_US
dc.subjectcarbapenemaseen_US
dc.subjectcolistinen_US
dc.subjectgentamicinen_US
dc.subjectmethyltransferaseen_US
dc.subjectRNA 16Sen_US
dc.subjecttigecyclineen_US
dc.subjecttobramycinen_US
dc.subjectaminoglycosideen_US
dc.subjectantiinfective agenten_US
dc.subjectbacterial proteinen_US
dc.subjectmethyltransferaseen_US
dc.subjectRNA 16Sen_US
dc.subjectaminoglycoside resistanceen_US
dc.subjectantibiotic resistanceen_US
dc.subjectantibiotic sensitivityen_US
dc.subjectArticleen_US
dc.subjectbacterium isolateen_US
dc.subjectcohort analysisen_US
dc.subjectcontrolled studyen_US
dc.subjecthumanen_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectmajor clinical studyen_US
dc.subjectnonhumanen_US
dc.subjectobservational studyen_US
dc.subjectphylogenetic treeen_US
dc.subjectplasmiden_US
dc.subjectprevalenceen_US
dc.subjecttrimethoprim resistanceen_US
dc.subjectTurkey (republic)en_US
dc.subjectwhole genome sequencingen_US
dc.subjectcarbapenem-resistant Enterobacteriaceaeen_US
dc.subjectgeneticsen_US
dc.subjectKlebsiella infectionen_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectmicrobial sensitivity testen_US
dc.subjectprevalenceen_US
dc.subjectAminoglycosidesen_US
dc.subjectAnti-Bacterial Agentsen_US
dc.subjectBacterial Proteinsen_US
dc.subjectbeta-Lactamasesen_US
dc.subjectCarbapenem-Resistant Enterobacteriaceaeen_US
dc.subjectCohort Studiesen_US
dc.subjectHumansen_US
dc.subjectKlebsiella Infectionsen_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectMethyltransferasesen_US
dc.subjectMicrobial Sensitivity Testsen_US
dc.subjectPrevalenceen_US
dc.subjectRNA, Ribosomal, 16Sen_US
dc.titleHigh prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolatesen_US
dc.typearticleen_US
dc.departmentDBÜen_US
dc.identifier.issue12en_US
dc.identifier.volume71en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempIsler, B., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia, Infection Management Services, Princess Alexandra Hospital, Brisbane, Australia; Falconer, C., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia; Vatansever, C., Infectious Diseases and Clinical Microbiology, School of Medicine, Koç University, Istanbul, Turkey; Özer, B., Infectious Diseases and Clinical Microbiology, School of Medicine, Koç University, Istanbul, Turkey; Çınar, G., Infectious Diseases and Clinical Microbiology, Ankara University, School of Medicine, Ankara, Turkey; Aslan, A.T., Infectious Diseases and Clinical Microbiology, Hacettepe University, School of Medicine, Ankara, Turkey; Forde, B., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia; Harris, P., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia; Şimşek, F., Infectious Diseases and Clinical Microbiology, University of Health Sciences, Ministry of Health Prof Dr Cemil Taşçıoğlu City Hospital, Istanbul, Turkey; Tülek, N., Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Atilim University, Ankara, Turkey; Demirkaya, H., Infectious Diseases and Clinical Microbiology, Başkent Universien_US
dc.identifier.pmid36748503en_US
dc.identifier.scopus2-s2.0-85147460921en_US
dc.identifier.wosWOS:001129579900012en_US
dc.authorscopusid57206274628
dc.authorscopusid57221350758
dc.authorscopusid57214119170
dc.authorscopusid57210635288
dc.authorscopusid57210793543
dc.authorscopusid57208546633
dc.authorscopusid35746149500


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record